China Polymerase Chain Reaction Market Size & Outlook

The polymerase chain reaction market in China is expected to reach a projected revenue of US$ 2,340.1 million by 2033. A compound annual growth rate of 7.5% is expected of China polymerase chain reaction market from 2026 to 2033.
Revenue, 2025 (US$M)
$1,313.6
Forecast, 2033 (US$M)
$2,340.1
CAGR, 2026 - 2033
7.5%
Report Coverage
China

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China polymerase chain reaction market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China polymerase chain reaction market highlights

  • The China polymerase chain reaction market generated a revenue of USD 1,313.6 million in 2025 and is expected to reach USD 2,340.1 million by 2033.
  • The China market is expected to grow at a CAGR of 7.5% from 2026 to 2033.
  • In terms of segment, conventional pcr was the largest revenue generating type in 2025.
  • Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.


Polymerase chain reaction market data book summary

Market revenue in 2025USD 1,313.6 million
Market revenue in 2033USD 2,340.1 million
Growth rate7.5% (CAGR from 2026 to 2033)
Largest segmentConventional pcr
Fastest growing segmentConventional PCR
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationConventional PCR
Key market players worldwideThermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth


Other key industry trends

  • In terms of revenue, China accounted for 8.6% of the global polymerase chain reaction market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,340.1 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Polymerase Chain Reaction Market Companies

Name Profile # Employees HQ Website
Microsynth View profile 11-50 Balgach, Sankt Gallen, Switzerland, Europe https://www.microsynth.ch/
Stilla View profile 1-10 San Francisco, California, United States, North America https://wearestilla.com/
Standard BioTools Inc View profile 539 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 https://www.standardbio.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

China polymerase chain reaction market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.


Conventional pcr was the largest segment with a revenue share of 16.85% in 2025. Horizon Databook has segmented the China polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2021 to 2033.


In addition, rising strategic initiatives such as licensing, partnerships, and collaboration to manufacture or distribute PCR products in different countries are anticipated to drive the market. The country can screen 51 million people daily. Moreover, with increasing homebased tests, the market has observed unprecedented opportunities. 

The number of new cases has decreased, and most patients have recovered. China, one of the world’s largest chemical producers, expedited the development of testing kits. China plays a crucial role in sending supplies for testing to other countries. 

More than 100 companies in China are selling kits to European countries. Nanjing Liming Bio-products produces around 600,000 kits per day and became the first company in the country to gain emergency approval to sell its real-time PCR tests in the U.S.

Reasons to subscribe to China polymerase chain reaction market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China polymerase chain reaction market databook

  • Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into China polymerase chain reaction market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China polymerase chain reaction market size, by type, 2021-2033 (US$M)

China Polymerase Chain Reaction Market Outlook Share, 2025 & 2033 (US$M)

China polymerase chain reaction market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online